Clinical CGT Immune Monitoring and Immunobiology Workshop

ABOUT THE COURSE

As cell and gene therapies (CGT) continue to advance, standardizing immune monitoring is critical to ensure consistent patient outcomes and generate comparable data across clinical sites. The Clinical CGT Immune Monitoring and Immunobiology Workshop is a one-day, expert-led program designed for clinicians, scientists, process development associates, laboratory directors, and medical students focused on advancing CGT patient care.

  • Track 1 – Technical & Translational Focus: Built for process development and translational scientists. Explore fit-for-purpose assay selection, biomarker integration, workflow optimization, and practical strategies to implement standardized immune monitoring across research and clinical settings.

  • Track 2 – Clinical Focus:  Designed for clinicians and clinical researchers. Learn novel immune monitoring strategies, implement robust biomarkers to support patient outcome prediction and follow-up, and translate immune data into actionable clinical decision-making.

Faculty will guide participants through discussions, case studies, and real-world examples, providing practical knowledge to implement and optimize immune monitoring strategies that enhance patient outcomes after CGT administration.

Special bundle pricing for this course is available with ISCT 2025 registration.

WHAT YOU WILL LEARN
  • Explain the importance of immune monitoring in optimizing clinical outcomes and supporting treatment decisions

  • Identify and interpret biomarkers to track immune responses and predict patient outcomes

  • Evaluate strategies to standardize immune monitoring workflows for improved consistency and data comparability across clinical sites, including flow cytometry and pharmacokinetic assays

  • Apply translational immunotechnology and best practices for implementing immune monitoring in research and process development

  • Select clinically relevant immune monitoring parameters for CAR-T and MSC therapies

  • Interpret multi-center data, understand sources of variability, and implement approaches for consistent results

  • Evaluate precision-enhancing assays and emerging technologies to support effective immune monitoring

  • Explore real-world examples to understand practical implementation and troubleshooting in immune monitoring


PRICE (USD)

Training Course + ISCT 2025 Annual Meeting  ISCT Members Non-Members
If you are registered for the Full Conference, attend this course for only $135. $135 
Training Course Only ISCT Members Non-Members
Student / Resident / Fellow / Postdoc $175 $240
Technologist / Pharmacist / Nurse Practitioner / Nurse $295 $425
Academia $325 $510
Industry $375 $560

Not an ISCT Member? Register now →

Note: If you do not see the correct rates during registration, please email us at workforcedevelopment@isctglobal.org .

For full details on our course policies, including cancellations, complaints and appeals processes and our privacy policy, click here.

In-person
1-day training
Tuesday, May 5, 2026

08:30-17:15 CST

Hosted in the ISCT 2026 Annual Meeting at:

Spencer Dock, N Wall Quay,
North Wall, Dublin 1, D01 T1W6, Ireland

UPON COMPLETION, YOU WILL RECEIVE:
  • Certificate of Course Completion from ISCT

Note: Completing all training modules and passing the quizzes is mandatory to receive a course completion certificate. 

DESIGNED FOR:
Track 1 (Technical / Process Development / Manufacturing Focus)
  • Process development associates responsible for translating research into clinical applications.
  • Laboratory directors overseeing the implementation of new technologies and processes into existing workflows.
  • Quality and clinical statisticians working to harmonize clinical trials data analysis.
Track 2 (Clinical Focus)
  • Advanced Practice Professionals (APPs), Physicians, and Early-Stage Professionals (ESPs) involved in follow-up testing and patient care after cell therapy infusions.
  • PhDs and MDs in translational research conducting clinical trials in cell and gene therapies, including oversight of patient outcomes.
  • Clinical and non-clinical scientists with an interest in immunobiology and therapeutic indications.
  • Laboratory professionals and support staff providing technical support in clinical research and patient monitoring.
  • Industry professionals from pharmaceutical and biotechnology sectors seeking a deeper understanding of clinical practices and patient follow-up to better align products and services with customer needs.
CONTACT US

    If you need help with registration or have questions, please contact us.

    PLANNING COMMITTEE
    Wade Atkins
    Jaap Boelens
    MD, PhD

    Chief, Transplantation and Cellular Therapies at Memorial Sloan Kettering Cancer Center,
    United States

    Lizette Caballero
    Stefan Nierkens
     PhD

    Medical Immunologist at UMC Utrecht and Princess Máxima Center for Pediatric Oncology, 
    Netherlands

    Lizette Caballero
    Elani Wiest
    PhD

    Associate Staff Scientist - Process Development at Mayo Clinic,
    United States

    CME ACCREDITATION

    Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM for physicians.

    Physicians should claim only the credit commensurate with the extent of their participation in the activity.